695 related articles for article (PubMed ID: 18217156)
1. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
Lobo B; Finch C; Howard A; Minhas S
Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
[TBL] [Abstract][Full Text] [Related]
2. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
Warkentin TE
Thromb Haemost; 2008 Jan; 99(1):2-3. PubMed ID: 18217128
[No Abstract] [Full Text] [Related]
3. Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.
Grouzi E; Kyriakou E; Panagou I; Spiliotopoulou I
Clin Appl Thromb Hemost; 2010 Dec; 16(6):663-7. PubMed ID: 19825921
[TBL] [Abstract][Full Text] [Related]
4. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues.
Blackmer AB; Oertel MD; Valgus JM
Ann Pharmacother; 2009 Oct; 43(10):1636-46. PubMed ID: 19737996
[TBL] [Abstract][Full Text] [Related]
5. Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.
Wester JP; Leyte A; Oudemans-van Straaten HM; Bosman RJ; van der Spoel JI; Haak EA; Porcelijn L; Zandstra DF
Neth J Med; 2007 Mar; 65(3):101-8. PubMed ID: 17387236
[TBL] [Abstract][Full Text] [Related]
6. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.
Efird LE; Kockler DR
Ann Pharmacother; 2006; 40(7-8):1383-7. PubMed ID: 16788093
[TBL] [Abstract][Full Text] [Related]
7. The approach to heparin-induced thrombocytopenia.
Linkins LA; Warkentin TE
Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia.
Snodgrass MN; Shields J; Rai H
Clin Appl Thromb Hemost; 2016 Nov; 22(8):712-717. PubMed ID: 27179015
[TBL] [Abstract][Full Text] [Related]
9. Fondaparinux as a treatment option for heparin-induced thrombocytopenia.
Papadopoulos S; Flynn JD; Lewis DA
Pharmacotherapy; 2007 Jun; 27(6):921-6. PubMed ID: 17542773
[TBL] [Abstract][Full Text] [Related]
10. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia.
Srinivasan AF; Rice L; Bartholomew JR; Rangaswamy C; La Perna L; Thompson JE; Murphy S; Baker KR
Arch Intern Med; 2004 Jan; 164(1):66-70. PubMed ID: 14718324
[TBL] [Abstract][Full Text] [Related]
11. Application, tolerance and safety of fondaparinux therapy in a German hospital: a prospective single-centre experience.
Schindewolf M; Scheuermann J; Kroll H; Marzi I; Kaufmann R; Boehncke WH; Ludwig RJ; Lindhoff-Last E
Thromb Res; 2012 Jan; 129(1):17-21. PubMed ID: 21741076
[TBL] [Abstract][Full Text] [Related]
12. Successful use of fondaparinux early after mechanical aortic valve replacement in a patient with a history of heparin-induced thrombocytopenia.
Willenborg KL
Pharmacotherapy; 2014 Jun; 34(6):e55-9. PubMed ID: 24644124
[TBL] [Abstract][Full Text] [Related]
13. The HIT treatment in a cardiac surgery patient.
Anna N; Boyan T; Kader MA; Catherine M; Matthias K
Int J Cardiol; 2010 Oct; 144(3):405-7. PubMed ID: 19324432
[TBL] [Abstract][Full Text] [Related]
14. Successful use of fondaparinux in a child with heparin-induced thrombocytopenia.
Tokgoz H; Caliskan U; Demir M
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):769-71. PubMed ID: 22964766
[TBL] [Abstract][Full Text] [Related]
15. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation with fondaparinux for hemodiafiltration in patients with heparin-induced thrombocytopenia: dose-finding study and safety evaluation.
Mahieu E; Claes K; Jacquemin M; Evenepoel P; Op De Beek K; Bogaert AM; Kuypers D; Verhamme P; Meijers B
Artif Organs; 2013 May; 37(5):482-7. PubMed ID: 23461610
[TBL] [Abstract][Full Text] [Related]
17. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.
Gettings EM; Brush KA; Van Cott EM; Hurford WE
Crit Care; 2006; 10(6):R161. PubMed ID: 17109753
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
Seculini Patiño CE; Pascualini MF; Tabares AH
Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
[TBL] [Abstract][Full Text] [Related]
19. Delayed-onset heparin-induced thrombocytopenia type-2 during fondiparinux (Arixtra) therapy.
Modi C; Satani D; Cervellione KL; Cervantes J; Gintautas J
Proc West Pharmacol Soc; 2009; 52():5-7. PubMed ID: 22128408
[TBL] [Abstract][Full Text] [Related]
20. HITlights: a career perspective on heparin-induced thrombocytopenia.
Warkentin TE
Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]